Envoy Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	25.25	3.74	5.48	4.22	0.18	0.15
Cash & Short-Term Investments	25.25	3.74	5.48	4.22	0.18	0.15
Cash Growth	375.36%	-31.81%	29.99%	2204.92%	22.13%	-
Accounts Receivable	0.03	0.03	0.04	0.07	0.04	-
Other Receivables	0.02	0.02	0.78	0.18	-	-
Total Trade Receivables	0.05	0.05	0.82	0.25	0.04	-
Inventory	1.49	1.55	1.71	1.4	1.3	-
Other Current Assets	0.89	0.94	0.89	1.59	0.13	1.72
Total Current Assets	27.68	6.28	8.9	7.46	1.65	0.86
Net Property, Plant & Equipment	1.82	1.92	2.15	0.82	0.91	-
Long-Term Investments	-	-	-	-	-	425.04
Other Long-Term Assets	0.33	0.36	0.49	-	-	-
Total Assets	29.82	8.56	11.54	8.27	2.56	426.9
Accounts Payable	1.7	2.92	1.65	1.55	1	0.62
Accrued Expenses	9.65	7.64	4.42	4.61	0.61	2.06
Current Portion of Long-Term Debt	-	-	-	-	0.45	-
Current Portion of Leases	0.18	0.17	0.14	0.16	0.13	-
Other Current Liabilities	0.68	0.83	1.33	0.96	0.34	-
Total Current Liabilities	12.21	11.56	7.54	7.29	2.52	2.68
Long-Term Debt	-	-	18.72	-	33.4	-
Long-Term Leases	0.71	0.75	0.8	0.4	0.57	-
Other Long-Term Liabilities	6.35	8.02	3.32	2.36	2.27	35.94
Total Long-Term Liabilities	7.06	8.76	22.84	2.76	36.23	35.94
Total Liabilities	19.27	20.33	30.38	10.05	38.75	38.62
Common Stock	0.01	0	0	0	0	0
Additional Paid-in Capital	329.37	301.36	266.01	255.6	189.9	-
Accumulated Other Comprehensive Income	-0.12	-0.12	-0.12	-0.12	-0.12	-
Retained Earnings	-319.1	-313.4	-284.73	-257.26	-225.99	-36.71
Total Common Shareholders' Equity	10.16	-12.16	-18.84	-1.78	-36.2	-36.71
Minority Interest	0.39	0.39	-	-	-	425
Shareholders' Equity	10.55	-11.77	-18.84	-1.78	-36.2	388.29
Total Liabilities & Equity	29.82	8.56	11.54	8.27	2.56	426.9
Total Debt	0.89	0.92	19.66	0.56	34.54	0
Net Cash (Debt)	24.36	2.82	-14.18	3.66	-34.35	0.15
Net Cash Growth	763.90%	-	-	-	-	-
Net Cash Per Share	0.69	0.12	-0.76	0.30	-3.39	0.01
Book Value	10.16	-12.16	-18.84	-1.78	-36.2	-36.71
Book Value Per Share	0.29	-0.52	-1.00	-0.14	-3.58	-3.63
Tangible Book Value	10.16	-12.16	-18.84	-1.78	-36.2	-36.71
Tangible Book Value Per Share	0.29	-0.52	-1.00	-0.14	-3.58	-3.63

SEC Filings: 10-K · 10-Q